ESR1 and breast cancer: We demonstrated the absence of a significant differencebetween ER+ and ER– breast cancer cell lines in their response tocytotoxic stimuli: treatment with high doses of phytoestrogens (apigenin,genistein, quercetin, naringenin) had the same efficiency in ER-positive andER-negative cells.